VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.45 Million in Teladoc Health, Inc. $TDOC

Key Points

• Virginia Retirement Systems acquired 170,625 Teladoc Health shares worth approximately $1.45 million in the second quarter, while institutional investors collectively own 76.82% of the company.
• Teladoc reported a quarterly loss of $0.21 per share, beating estimates, but revenue fell 4% year over year to $606.93 million and the company maintained negative margins.
• Analyst sentiment remains mixed, with five Buy, ten Hold and one Sell rating; the consensus rating is Hold with a $7.54 price target, compared with a recent share price of $6.16.

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 170,625 shares of the health services provider's stock, valued at approximately $1,447,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned 0.09% of Teladoc Health as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Renaissance Technologies LLC grew its holdings in Teladoc Health by 1.3% during the first quarter. Renaissance Technologies LLC now owns 8,085,542 shares of the health services provider's stock worth $44,066,000 after acquiring an additional 107,400 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Teladoc Health by 8.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,494,255 shares of the health services provider's stock valued at $52,459,000 after acquiring an additional 605,061 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Teladoc Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 4,188,313 shares of the health services provider's stock valued at $29,324,000 after purchasing an additional 18,394 shares in the last quarter. Jupiter Asset Management Ltd. boosted its position in shares of Teladoc Health by 293.9% during the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider's stock valued at $27,021,000 after purchasing an additional 2,880,008 shares in the last quarter. Finally, Pale Fire Capital SE grew its stake in shares of Teladoc Health by 74.8% in the 1st quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider's stock worth $18,522,000 after purchasing an additional 1,454,288 shares during the last quarter. Institutional investors own 76.82% of the company's stock.

Teladoc Health Price Performance

TDOC stock opened at $6.16 on Friday. Teladoc Health, Inc. has a 52-week low of $4.40 and a 52-week high of $9.89. The company's 50 day simple moving average is $7.51 and its 200-day simple moving average is $6.75. The firm has a market capitalization of $1.12 billion, a P/E ratio of -6.22 and a beta of 2.12.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The business had revenue of $606.93 million during the quarter, compared to the consensus estimate of $615.44 million. During the same quarter in the prior year, the firm earned ($0.19) EPS. The firm's quarterly revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. Sell-side analysts predict that Teladoc Health, Inc. will post -0.9 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several recent research reports. Bank of America increased their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a research note on Tuesday, July 7th. Canaccord Genuity Group dropped their price target on Teladoc Health from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, July 30th. Citigroup cut their price objective on Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research report on Monday, August 3rd. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Five investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and a consensus price target of $7.54.

Teladoc Health Company Profile

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company's offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.